Branford Castle-Backed Lafayette Instrument Acquires Avisoft Bioacoustics

Lafayette Instrument, LLC, a prominent global manufacturer of scientific instrumentation, has acquired Avisoft Bioacoustics, a leader in ultrasonic vocalization research, for an undisclosed amount. The transaction, announced on July 29, 2026, marks Lafayette's sixth bolt-on investment since its acquisition by Branford Castle Partners' Fund II in 2021, further solidifying its position in the life sciences instrumentation sector.

Lafayette Instrument, with over 75 years of experience, specializes in engineering and manufacturing high-quality scientific tools across various disciplines, including biology, neuroscience, and medical research. The company's commitment to innovation and quality has positioned it as a key player in the life sciences market. Avisoft Bioacoustics complements this portfolio by offering integrated hardware and software solutions, particularly in ultrasonic vocalization (USV) research. Its products, which include advanced ultrasonic microphones, are widely utilized by academic institutions and research organizations globally, underpinning thousands of peer-reviewed publications.

The strategic rationale behind this acquisition lies in Lafayette's objective to enhance its product offerings and technological capabilities in the life sciences domain. By integrating Avisoft's expertise and product line, Lafayette aims to better serve a growing customer base that demands cutting-edge tools for scientific research. The acquisition aligns with Lafayette's ongoing strategy to expand its life sciences instrumentation platform and reinforces its commitment to providing unparalleled support to researchers.

The life sciences sector is experiencing robust growth, driven by increasing investments in research and development, particularly in areas like neuroscience and bioacoustics. This acquisition positions Lafayette Instrument to capitalize on these trends by broadening its capabilities and enhancing its competitive edge. The integration of Avisoft's technologies is expected to foster innovation and drive long-term growth, as Lafayette continues to build on its momentum in the market.

Overall, this transaction underscores the active consolidation within the life sciences instrumentation sector, as companies seek to enhance their product offerings and technological expertise. The acquisition of Avisoft Bioacoustics not only strengthens Lafayette's portfolio but also reflects the increasing demand for specialized tools and solutions in scientific research, setting the stage for further developments in this dynamic market.